NZ597776A - Compounds for the prevention and treatment of cardiovascular diseases - Google Patents

Compounds for the prevention and treatment of cardiovascular diseases

Info

Publication number
NZ597776A
NZ597776A NZ597776A NZ59777607A NZ597776A NZ 597776 A NZ597776 A NZ 597776A NZ 597776 A NZ597776 A NZ 597776A NZ 59777607 A NZ59777607 A NZ 59777607A NZ 597776 A NZ597776 A NZ 597776A
Authority
NZ
New Zealand
Prior art keywords
prevention
compounds
treatment
cardiovascular diseases
cardiovascular
Prior art date
Application number
NZ597776A
Inventor
Henrik Hansen
Original Assignee
Resverlogix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resverlogix Corp filed Critical Resverlogix Corp
Priority to NZ597776A priority Critical patent/NZ597776A/en
Priority claimed from NZ579355A external-priority patent/NZ579355A/en
Publication of NZ597776A publication Critical patent/NZ597776A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

597776 COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
NZ597776A 2007-02-01 2007-02-01 Compounds for the prevention and treatment of cardiovascular diseases NZ597776A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ597776A NZ597776A (en) 2007-02-01 2007-02-01 Compounds for the prevention and treatment of cardiovascular diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ597776A NZ597776A (en) 2007-02-01 2007-02-01 Compounds for the prevention and treatment of cardiovascular diseases
NZ579355A NZ579355A (en) 2007-02-01 2007-02-01 2-(Aryl)-4-oxo-quinazoline derivatives

Publications (1)

Publication Number Publication Date
NZ597776A true NZ597776A (en) 2013-03-28

Family

ID=48575101

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ597776A NZ597776A (en) 2007-02-01 2007-02-01 Compounds for the prevention and treatment of cardiovascular diseases

Country Status (1)

Country Link
NZ (1) NZ597776A (en)

Similar Documents

Publication Publication Date Title
HK1136283A1 (en) Compounds for the prevention and treatment of cardiovascular diseases
WO2010079431A3 (en) Compounds for the prevention and treatment of cardiovascular disease
TR201909777T4 (en) ORAL RELEASE RELEASE FORMULATIONS FOR SUBSTITUTED QINAZOLINONES
MX2009013990A (en) Methods of treating serotonin-mediated diseases and disorders.
EA200900828A1 (en) COMPOUNDS AND COMPOSITIONS AS AN INHIBITOR ACTIVITY OF THE CANANABINOID RECEPTOR 1
TN2010000140A1 (en) Compositions and methods for use antibodies against sclerostin
TN2012000081A1 (en) Compounds and compositions as protein kinase inhibitors
SG179410A1 (en) Therapeutic uses of inhibitors of rtp801
TW200612892A (en) Novel compounds
TW200732296A (en) Novel compounds
AU2012277802A8 (en) Novel inhibitor compounds of phosphodiesterase type 10A
ECSP088852A (en) AZOLOPIRIMIDINS AS INHIBITORS OF CANABINOID ACTIVITY 1
EA200901166A1 (en) CONNECTIONS AND COMPOSITIONS AS GPR 119 ACTIVITY MODULATORS
MX2009011754A (en) Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme.
TW200745003A (en) Novel compounds
EA201100749A1 (en) DERIVATIVES OF PYRIDINE AND PYRIMIDINE AS INHIBITORS OF PHOSPHODYSTERASE 10
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
MX2009003981A (en) Calcium receptor modulating agents.
MX2007011847A (en) Pyrimidindione derivatives as prokineticin 2 receptor antagonists.
EA200971050A1 (en) METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS
WO2008011611A3 (en) Compounds and compositions as itpkb inhibitors
MX2012001134A (en) Compositions and methods for inhibition of the jak pathway.
MX340807B (en) Novel compositions for preventing and/or treating degenerative disorders of the central nervous system.
MX2009011753A (en) Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme.

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE MISSING CONTACT HAS BEEN ADDED (600168, CULLENS, # 4817, PO BOX 83000, WELLINGTON 6440, NZ)

Effective date: 20130307

Free format text: THE AGENT HAS BEEN CORRECTED TO 600168, CULLENS, # 4817, PO BOX 83000, WELLINGTON 6440, NZ; 1441794, IPONZ, 2. , 205 VICTORIA STREET, TE ARO, WELLINGTON 6011, NZ; THE CONTACT HAS BEEN CORRECTED TO 1441794, IPONZ, 2. , 205 VICTORIA STREET, TE ARO, WELLINGTON 6011, NZ

Effective date: 20130306

Free format text: THE AGENT HAS BEEN CORRECTED TO 600168, CULLENS, # 4817, PO BOX 83000, WELLINGTON 6440, NZ; THE CONTACT HAS BEEN CORRECTED TO 600168, CULLENS, # 4817, PO BOX 83000, WELLINGTON 6440, NZ

Effective date: 20130306

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 01 FEB 2014 BY CULLENS

Effective date: 20130806

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 01 FEB 2017 BY CPA GLOBAL

Effective date: 20131219

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2018 BY CPA GLOBAL

Effective date: 20161217

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2019 BY CPA GLOBAL

Effective date: 20171222

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2020 BY CPA GLOBAL

Effective date: 20181220

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2021 BY CPA GLOBAL

Effective date: 20191219

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2022 BY CPA GLOBAL

Effective date: 20201218

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2023 BY CPA GLOBAL

Effective date: 20211216

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2024 BY CPA GLOBAL

Effective date: 20221216

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 FEB 2025 BY CPA GLOBAL

Effective date: 20231221